To our customers: Please be assured that we are doing our very best to continue manufacturing and to get our products to you as quickly as possible. Unfortunately, due to staff shortages and changes to delivery services, we are experiencing delays with stock replenishment and delivery times. This is affecting both our next day services and our standard Royal Mail delivery times. We will keep you informed as the situation changes.

The Cambridge Clostridium difficile Study

Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea

Aim

This randomised, double-blind, placebo controlled study was designed to provide evidence that supplementing with Lab4 probiotics while taking antibiotics can prevent the incidence of antibiotic associated C. difficile diarrhoea (CDAD).

Method

  • The study was carried out at Addenbrooke’s Hospital in Cambridge.
  • 138 elderly patients requiring antibiotic therapy were divided into two equal groups.
  • The first group received 25 billion Lab4 probiotics daily in conjunction with their prescribed antibiotics, for 20 days.
  • The second group took a placebo with their prescribed antibiotics.
  • The efficacy of Lab4 probiotics in the prevention of CDAD was assessed by recording bowel habit and analysing faecal samples.

The results

  • The patient group given Lab4 probiotics experienced a lower incidence of Clostridium difficile diarrhoea compared to the placebo group.
  • This effect was due to a reduction in the presence of the Clostridium difficile toxin in the Lab4 probiotic group.
% of patients positive for Clostridium difficile associated diarrhoea
% of patients positive for Clostridium difficile associated diarrhoea
% of patients positive for Clostridium difficile toxin
% of patients positive for Clostridium difficile toxin

Conclusion

Supplementation with Lab4 probiotics can reduce the incidence of C. difficile diarrhoea in hospitalised patients.

Reference

Plummer S et al  2004.
Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea.
International Microbiology, 7:59-62

Practitioner Accounts

Get access to our new ProVen Probiotics Practitioner Range

Apply Now

View More Studies

ProVen Probiotics are supported by a large body of research, which includes both in-vivo and in-vitro trials...

View Studies
Scroll to Top

Areas of Research

Category Menu Immunity
Immunity
Category Menu Gastro Intestinal Health
Gastro-Intestinal Health
Category Menu Early Immune System Development
Early Immune System Development
Category Menu Cognitive Function
Cognitive
Category Menu Performance
Performance
Category Menu Safety
Safety
ProVen Probiotics in-vitro, ex-vivo and animal studies
Other
Pro-Ven Probiotics main logo 2019 small

50 billion - Shapeline

Gold standard Lactobacillus & Bifidus for a ‘Shapelier You’

6 for 4 bundle on 50 Billion banner - ShapeLine from ProVen Probiotics